Antipsychotic Profile of Alstonine: Ethnopharmacology of a Traditional Nigerian Botanical Remedy

Anais da Academia Brasileira de Ciencias

Volumn 71, Issue 2, 1999, Pages 187-199

  Costa Campos, L ^a   Elisabetsky, Elaine ^a   Lara, D R ^a   Carlson, T J ^b   King, S R ^b   Ubillas, R ^b   Nunes, D S ^c   Iwu, M M ^d   Nkemjika, Cosmas Obialor ^d   Ozioko, Alfred ^d   Agwu, Charles O C ^d  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^b Shaman Pharmaceuticals Inc   (United States)

^c Campus de Uvaranas   (Brazil)

^d UNIVERSITY OF NIGERIA   (Nigeria)

Author keywords

Alstonine; Antipsychotic; Dopamine; Serpentine alkaloids

Indexed keywords

EID: 0347183069     PISSN: 00013765     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. BALDESSARINI, R. J., (1996), Drugs and the Treatment of Psychotric Disorders. In: HARDMAN, J. G., GILMAN, A. G. & LIMBIRD, L. E. eds., Goodman and Gilmann's. The Pharmacological Basis of Terapeutics, 399-430.
2. BORIN, M.: POISSON, L & LAROUSSI, C., (1986), Piracetam interaction with neuroleptics in psychopharmacological tests. Neuropsychobiology, 19: 93-96.
3. BUNNEY, B. G.; BUNNEY, JR., W. E. & CARLSSON, A., (1995), Schizophrenia and Glutamate. In: BLOOM, F. E. & KUPFER, D. J. Psychopharmacology: The Fourth Generation of Progress. Raven Press, Ltd., New York, 1205-1214.
4. CHOUINARD, G.; JONES, B.; REMINGON, G.; BLOOM, D.; ADDINGTON, D.; MACEWAN, G. W.; LABELLE, A.; BLAUCLAIR, L & ARNOTT, W., (1993), A Canadian Multicenter Placebo-Controlled Study of Fixed Doses of Risperidone and Haloperidol in the Treatment of Chronic Schizophrenic Patients, J. Clin. Psychopharmacol, 13: 25-40.
5. COSLA-CAMPOS, L.; LARA, D. R.; NUNES, D. S. & ELISABETSKY, E., (1998a), Antipsychotic-like Profile of Alstonine. Pharmacology Biochemistry and Behavior, 60 (1): 133-141.
6. COSTA-CAMPOS, L.; LARA, D. R.; NUNES, D. S.; ELISABETSKY, E.; CARLSSON, T. J.; UBILLAS, R.; KING, S. & IWU, M., (1998b), "Antipsychotic profile of alstonine: ethnopharmacology of a traditional Nigerian botanical remedy". Acta Horticulturae, vol. 2, in press.
7. COSTALL, B. & NAYLOR, R. J., (1974), On catalepsy and catatonia and the predictability of the catalepsy test for neuroleptic activity. Psychopharmacologia, 34: 233-241.
8. COWARD, D. M., (1992), General pharmacology of clozapine. Br. J. Psychiatry, 160: 5.
9. ELLENBROEK, B. A., (1993), Treatment of Schizophrenia: a Clinical and Preclinical Evaluation of Neuroleptic Drugs. Pharmac. Ther., 57: 1-78.
10. EZRIN-WATERS, C.; MULLER, P. & SLEMAN, P., (1976), Catalepsy induced by morphine and haloperidol: effects of apomorphine and anti-cholinergic drugs, Can. J. Physiol. Pharmac., 54: 516-519.
11. HOLMSTEDL, B & BRUHN, J. G., (1983), Ethnopharmacology - a challenge. J. of Ethnopharmacol., 8: 251-256.
12. JACKSON, D. M. & WESTTIND-DANIELSSON, A., (1994), Dopamine receptors: molecular biology, biochemistry and behavioral aspects. Pharmac. Ther., 64: 291-369.
13. KANE, J. M. & LIEBERMAN, J. A., (1992), Adverse effects of psychotropic drugs. New York: Guilford Press.
14. KANE, J. M. & MARDER, S. R., (1993), Psychopharmacologic treatment of schizophrenia. Schizophrenia Bulletin, 19: 287-302.
15. MELTZER, H. Y., (1995), Atypical Antipsychotic Drugs. In: BLOOM, F. E. & KUPFER, D. J. Psychopharmacology: The Fourth Generation of Progress. Raven Press Ltd., New York, 1277-1286.
16. MOORE, N. A.; BLACKMAN, A.; AWERL, S. & LEANDER, J. D., (1993), NMDA receptor antagonists inhibit catalepsy induced by either dopamine D1 or D2 receptor antagonists. Eur. J. Pharmac., 237: 1-7.
17. ODEBIYL, A. L., (1990), Western trained nurses assessment of the different categories of traditional healers in southwestern Nigeria. Int. J. Nurse Stud., 25 (4): 333-342.
18. OPPONG, A. C. K., (1989), Healers in transition. Social Science and Medicine, 28 (6): 605-612.
19. PEARCE, T. O., (1989), The assessment of diviners and their knowledge by civil servants in Southwestern Nigeria. Social science and Medicine, 28 (9): 917-924.
20. PICKAR, D., (1995), Prospects for pharmacotherapy of schizophrenia. Lancet, 345: 557-562.
21. SELMAN, P.; LEE, T.; CHAN-WONG, M. & WONG, K., (1976), Antipsychotic drug doses and neuroleptic/dopamine receptors. Nature, 261: 717-719.
22. SHORE, P. A. & GIACHETTE, A., (1978), Reserpine: basic and clinical pharmacology. In: IVERSEN, L. L., IVERSEN, S. D. & SNYDER, S. H. eds. Handbook of psychopharmacology, vol. 10, Plenum Press, New York, 471-490.
23. SOPOWORA, A., (1982), Medicinal plants and traditional medicine in Africa. John Wiley. Chincherster, UK.
24. WADDINGTON, J. L. & GAMBLE, S. J., (1980), Differential effect of aging on distinct features of apomorphine stereotypy in the adult rat. Neuroscience Letters, 20: 95-99.
25. WILLNER, P., (1984), The validity of animal models of depression. Psychopharmacology, 83: 1-16.
26. 3-benzilthymidine on mice. Life Sciences, 41: 2791-2797.